Migraine is the second leading cause of disability worldwide. New data show the number of patients who will need care by clinicians with expertise in neurological conditions will continue to grow in coming decades.
This Week on NeurologyLive® — April 22, 2024
Episode 92: Highlights From the 2023 CMSC, SLEEP, AHS, and ATMRD Annual Meetings
Efficacy and Safety of Fremanezumab Consistent in Patients With Migraine and Obesity
Episode 88: 2023 AAN Annual Meeting Highlights
Long-Term Atogepant Effective, Safe as Migraine Preventive, Open-Label Studies Show
This Week on NeurologyLive® — April 15, 2024